Manual_digital

Cuidados

Continuos

268

BIBLIOGRAFÍA

Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. Chronic

Dis 1970;23: 455-469

Søgaard M, Thomsen RW, Bossen KS, Sørensen HT, Nørgaard M. The impact of comorbidity

on cancer survival: a review. Clin Epidemiol. 2013 Nov 1;5(Suppl 1):3-29

Edwards BK, Noone AM, Mariotto AB, Simard EP, Boscoe FP, Henley SJ, et al. Annual Report

to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and

impacton survival among persons with lung, colorectal, breast, or prostate cancer. Cancer.

2013 Dec 16. [Epub ahead of print]

Lash TL, Mor V, Wieland D, Ferrucci L, Satariano W, Silliman RA. Methodology, design, and

analytic techniques to address measure¬ment of comorbid disease. J Gerontol A Biol Sci Med

Sci. 2007;62(3): 281–285.

de Groot, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity: a critical

review of available methods. J Clin Epidemiol 2003; 56 (3): 221-9

Balducci L. New Paradigms for Treating Elderly Patients With Cancer: The Comprehensive

Geriatric Assessment and Guidelines for Supportive Care. J Support Oncol 2003;1:30–37

Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary

breast cancer. Ann Inter Med 1994; 120: 104-110.

Repetto L, Venturino A, Vercelli M, Gianni W, Biancardi V, Casella C, et al. Performance status

and comorbidity in elderly cancer patients compared with young patients with neoplasia and

elderly patients without neoplastic conditions. Cancer 1998; 82: 760-5.

Jørgensen TL, Hallas J, Friis S, Herrstedt J. Comorbidity in elderly cancer patients in relation

to overall and cancer-specific mortality. Br J Cancer. 2012;106(7):1353–1360.

Schonberg MA, Marcantonio ER, Li D, Silliman RA, Ngo L, McCarthy EP. Breast cancer among

the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol. 2010;

28(12):2038–2045

Grønberg BH1, Sundstrøm S, Kaasa S, Bremnes RM, Fløtten O, Amundsen T, Hjelde HH,

Plessen Cv, Jordhøy M. Influence of comorbidity on survival, toxicity and health-related

quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet

chemotherapy. Eur J Cancer. 2010;46(12):2225-34.

Froehner M, Koch R, Litz R, Oehlschlaeger S, Wirth MP. Which conditions contributing to the

Charlson score predict survival after radical prostatectomy. J. Urol 2004; 171: 697-9.

Feinstein A.R., Schimpff C.R., Andrews J.F., Wells C.K. Cancer of the larynx: a new staging

system and re-appraisal of prognosis and treatment. J Chron Dis. 1977;30:277-305.

Peters TT, van Dijk BA, Roodenburg JL, van der Laan BF, Halmos GB. Relation between age,

comorbidity and complications in patients undergoing major surgery for head and neckcancer.

Ann Surg Oncol. 2014 Mar;21(3):963-70.

Ostenfeld EB, Nørgaard M, Thomsen RW, Iversen LH, Jacobsen JB, Comorbidity and survival

of Danish patients with colon and rectal cancer from 2000-2011: a population-based cohort

study. Clin Epidemiol. 2013 Nov 1;5 (Suppl 1):65-74.

Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW. Effects of age and comorbidity

in postmenopausal breast cancer patients aged 55 years and older. JAMA 2001; 21: 885-92.

10.

11.

12.

13.

14.

15.

16.